calcium citrate Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Calcium citrate malate is a water-soluble calcium supplement. It is the calcium salt of citric acid and malic acid with variable composition.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

calcarea gluconica | calcii gluconas | calciofon | calcium citrate | calcium citrate malate | calcium d-gluconate | calcium d-gluconate lactobionate | calcium di-gluconate | calcium glubionate | calcium glubionate anhydrous | calcium glubionate hydrate | calcium glubionate monohydrate | calcium gluconate | calcium gluconate anhydrous | calcium gluconate, anhydrous | calcium gluconate monohydrate | calcium médifa | calcium-sandoz | calc-sandoz | calglucon | citracal | (d-gluconato)(lactobionato)calcium | d-gluconic acid, calcium salt (2:1) | glubionate calcium | glubionate calcium monohydrate | h-f antidote | kaon | katorin | neo-calglucon | tricalcium citrate

Organizations (45)

Research & Development (43)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (30)

Approved Indications (1)


 

Hypocalcemia

Experimental Indications - Clinical Trial Phases 1-4 (29)


 

Acute Kidney Injury (Phase 3)

Alcoholism (Phase 3)

Anterior Cruciate Ligament Injuries (Phase 1)

Arthralgia (Phase 2)

Arthritis, Rheumatoid (Phase 4)

Bariatric Surgery (Phase 4)

Bone Diseases, Metabolic (Phase 3)

Breast Neoplasms (Phase 3)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 3)

Colorectal Neoplasms (Phase 3)

COVID-19 (Phase 2)

Dental Caries (Early Phase 1)

Diabetes Mellitus (Phase 1)

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Hemodialysis, Home (Phase 3)

Hyperphosphatemia (Phase 1)

Hypoparathyroidism (Phase 4)

Magnesium Deficiency (Phase 3)

Musculoskeletal Diseases (Phase 2)

Myopia (Phase 1)

Osteoporosis (Phase 4)

Ovarian Hyperstimulation Syndrome (Phase 2)

Pain (Phase 3)

Peripheral Nerve Injuries (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prostatic Neoplasms (Phase 3)

Renal Insufficiency, Chronic (Phase 1)

Sarcoidosis (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 33
  • # of Trial Organizations: 43

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue